Entering text into the input field will update the search result below

CymaBay Therapeutics stock gains after CEO buys shares worth $100K

Jun. 07, 2022 10:20 AM ETCymaBay Therapeutics, Inc. (CBAY) StockBy: Niloofer Shaikh, SA News Editor
  • CymaBay Therapeutics (NASDAQ:CBAY) stock edge higher after disclosing that its CEO Sujal Shah bought 51.301K shares of common stock on 6 June.
  • As per regulatory filing, shares were purchased at $1.95, for total transaction size of $100K.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CBAY--
CymaBay Therapeutics, Inc.